Matrix metalloproteinases (MMPs), tissue inhibitor of matrix metalloproteinases (TIMPs) and transforming growth factor-β (TGFβ) expression in small airways (SA) of usual idiopathic pneumonia (UIP), non-specific interstitial pneumonia (NSIP), hip Source: Annual Congress 2007 - Role of genomics and biological tools in the work-up of interstitial lung disease Year: 2007
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006
Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Matrix metalloproteinases in pulmonary fibrosis Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis Year: 2013
Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
Matrix metalloproteinases in tuberculosis Source: Eur Respir J 2011; 38: 456-464 Year: 2011
Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions Source: Eur Respir J 2005; 25: 104-109 Year: 2005
Matrix metalloproteinases and their inhibitors in pulmonary hypertension}, Source: Eur Respir J 2012; 40: 766-782 Year: 2012
Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
Expression of elastolytic matrix metalloproteinases in bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 228s Year: 2002
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients Source: Eur Respir J 2005; 25: 885-890 Year: 2005
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation Source: Eur Respir J 2009; 33: 134-141 Year: 2009
Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010